Market research
ESF.F Eurofins Scientific SE
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 137B
- P/E ratio
- 711.8
- Analyst target
- 32
- Dividend yield
- 0.5%
- Beta
- 0.74
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- Not available
- Market cap
- 137B
- P/E ratio
- 711.8
- Analyst target
- 32
- Dividend yield
- 0.5%
- Beta
- 0.74
About
About Eurofins Scientific SE
Eurofins Scientific SE, through its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic. It provides agro science, agro testing, biopharma, contract development and manufacturing organization, clinical diagnostics, consumer product testing, digital testing, electrical and electronics, environment testing, food and feed testing, forensic, genomic, industrial, materials and engineering, medical device, and REACH services. The company serves clients from a range of industries, including the pharmaceutical, food, environmental, and clinical diagnostics sectors. It operates approximately 800 laboratories in 50 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ESF.F discussion.
5 years, 5 months ago
Eurofins Scientific SE is currently in a long term uptrend where the price is trading 24.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Based on the above factors, Eurofins Scientific SE gets an overall score of 2/5.